1. Home
  2. ADMA vs FNB Comparison

ADMA vs FNB Comparison

Compare ADMA & FNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • FNB
  • Stock Information
  • Founded
  • ADMA 2004
  • FNB 1864
  • Country
  • ADMA United States
  • FNB United States
  • Employees
  • ADMA N/A
  • FNB N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • FNB Major Banks
  • Sector
  • ADMA Health Care
  • FNB Finance
  • Exchange
  • ADMA Nasdaq
  • FNB Nasdaq
  • Market Cap
  • ADMA 5.1B
  • FNB 5.6B
  • IPO Year
  • ADMA N/A
  • FNB N/A
  • Fundamental
  • Price
  • ADMA $16.11
  • FNB $16.41
  • Analyst Decision
  • ADMA Strong Buy
  • FNB Strong Buy
  • Analyst Count
  • ADMA 3
  • FNB 9
  • Target Price
  • ADMA $27.67
  • FNB $18.33
  • AVG Volume (30 Days)
  • ADMA 2.9M
  • FNB 8.6M
  • Earning Date
  • ADMA 11-06-2025
  • FNB 10-16-2025
  • Dividend Yield
  • ADMA N/A
  • FNB 2.92%
  • EPS Growth
  • ADMA 469.09
  • FNB 8.45
  • EPS
  • ADMA 0.85
  • FNB 1.29
  • Revenue
  • ADMA $474,174,000.00
  • FNB $1,546,100,000.00
  • Revenue This Year
  • ADMA $21.08
  • FNB $16.96
  • Revenue Next Year
  • ADMA $25.98
  • FNB $8.57
  • P/E Ratio
  • ADMA $19.06
  • FNB $12.74
  • Revenue Growth
  • ADMA 43.58
  • FNB 4.25
  • 52 Week Low
  • ADMA $13.50
  • FNB $10.88
  • 52 Week High
  • ADMA $25.67
  • FNB $17.70
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 37.77
  • FNB 56.37
  • Support Level
  • ADMA $15.74
  • FNB $16.26
  • Resistance Level
  • ADMA $17.17
  • FNB $16.59
  • Average True Range (ATR)
  • ADMA 0.52
  • FNB 0.28
  • MACD
  • ADMA -0.09
  • FNB -0.05
  • Stochastic Oscillator
  • ADMA 18.81
  • FNB 32.88

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About FNB F.N.B. Corporation

F N B Corp provides a full range of financial services, principally to consumers, corporations, governments and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.

Share on Social Networks: